This is the authors' abstract. We don't add key points for this paper.
Combining supporting cell-specific gene delivery via the adenovirus serotype 28 vector with a low-strength long expressing promoter potentially can provide long-term neurotrophin delivery to the damaged inner ear.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Peter et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: